How long can a person with a mediastinal tumor live

Many people want to know what a mediastinal tumor is and how long a patient can live with it. In fact, the mediastinum refers to the human chest cavity, and a mediastinal tumor is naturally a mass that grows inside the human chest cavity. Most mediastinal tumors are benign, and very few are malignant. Therefore, if you have a mediastinal tumor, don’t worry too much. A benign tumor can fully recover after surgical removal, and it will not affect your life expectancy. Mediastinal tumors can generally occur at any age and have attracted great attention.

Because the mediastinum occupies a large area, there are many methods to artificially divide the mediastinum into several regions. Traditionally, the mediastinum is divided into four regions: superior, anterior, middle, and posterior. There are also methods to divide it into three subregions: anterior superior, middle, and posterior. The various zones of the mediastinum are artificially delineated clinically and have no precise anatomical boundaries, so the zones usually overlap.

Many mediastinal tumor patients and their families have been concerned about how long they can live. In this regard, oncologists say: There is no clear answer to how long patients with advanced mediastinal tumors can live, because this question involves many factors. How long patients with advanced mediastinal tumors can live depends on the treatment method and the patient's own function. Let’s take a look at it together below.

How long patients with late-stage mediastinal tumors can live depends on the effectiveness of treatment and their physical functions. As long as they choose the right method and actively treat it, they can improve symptoms and prolong their survival. Patients with late-stage mediastinal tumors should maintain an optimistic attitude and actively cooperate with treatment. With the continuous improvement of treatment methods, new treatment methods and drugs are emerging in an endless stream. In terms of treatment methods, traditional surgery, radiotherapy, chemotherapy and other treatments are not effective for patients with advanced mediastinal tumors with lymph node metastasis and multiple visceral lesions and metastases, as well as elderly and frail patients who are not suitable for surgery, radiotherapy and chemotherapy. Surgery is powerless against tiny lesions, cannot eliminate residual cancer cells, and cannot break up the soil on which cancer cells depend for survival, so it is easy to cause metastasis and recurrence. The side effects of radiotherapy and chemotherapy are also relatively harmful to the body and can reduce the patient's immune and anti-cancer ability. Elderly and weak patients cannot tolerate it and their condition will be aggravated.

The treatment of tumors is no longer the traditional single surgery or radiotherapy and chemotherapy. Instead, we adopt a multidisciplinary and multi-method combined treatment method to primarily enhance the immune anti-cancer ability; at the same time, we use traditional Chinese medicine as a supplement. Traditional Chinese medicine has a long history and is profound and can cure the root cause. In addition, the mentality is very important. Don't be afraid or anxious, otherwise it will only aggravate the condition. If this can be achieved, the patient's life span can be significantly extended. Early treatment is obviously effective and can restore the patient to a normal life. Patients with mid- to late-stage metastatic mediastinal tumors can improve their life expectancy by 5-10 years, or even longer. In addition, the combination of multidisciplinary and multi-method treatment methods has changed the past phenomenon that various single treatment methods could not effectively coordinate with each other, often resulting in repeated over-treatment of patients, delaying their condition, seriously endangering their lives, and increasing the cost burden on cancer patients. Therefore, multidisciplinary comprehensive treatment can effectively reduce the economic burden of patients.

Oncology experts remind patients not to let the question of how long they can live with late-stage mediastinal cancer affect their mood for treatment, and they should not believe advertisements that claim a certain drug can make patients with late-stage mediastinal cancer live longer. There is no definite answer to the question of how long a patient with late-stage mediastinal tumor can live. The most important thing is to receive scientific and regular treatment as soon as possible.